Open access
Open access
Powered by Google Translator Translator

Randomized phase 2 trial: SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with Covid-19

29 Oct, 2020 | 09:16h | UTC

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19 – New England Journal of Medicine

Audio Interview: A New Monoclonal Antibody for Covid-19 – New England Journal of Medicine

 

Commentaries on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.